Section of Urogynecology and Reconstructive Pelvic Surgery, Department of Gynecology, Cleveland Clinic Florida, Weston, Florida, USA.
Curr Opin Obstet Gynecol. 2012 Oct;24(5):343-8. doi: 10.1097/GCO.0b013e328357a1c5.
To review the known causes, presentation, and management of synthetic mesh exposure and other healing abnormalities associated with transvaginal implantation for pelvic organ prolapse.
The recent restriction of mesh used in urogynecology to type 1 monofilament/macroporous mesh has led to recognizable patterns of healing abnormality development. Excision of exposed or contracted mesh segments usually leads to symptom resolution. There are various surgical techniques recognized to reduce the risk of exposure development. Pain, when associated with mesh use, may be more challenging to manage and may persist in a small percentage of patients. Surgeons should be aware of recently recognized risk factors for exposure development and carefully select patients for mesh implantation based on risk:benefit assessment.
The use of synthetic mesh implanted transvaginally for urogynecologic indications is associated with recognized risks, including exposure (approximately 10%) and contraction which can usually be managed successfully with local estrogen, in-office trimming, or surgical excision of the exposed or contracted segment.
回顾与经阴道植入盆腔器官脱垂治疗相关的合成网片暴露及其他愈合异常的已知病因、表现和处理方法。
最近，限制在妇科泌尿学中使用的网片为 1 型单丝/大孔网片，这导致了可识别的愈合异常发展模式。切除暴露或收缩的网片段通常可导致症状缓解。已经认识到各种手术技术可降低暴露发展的风险。与网片使用相关的疼痛可能更难处理，并且在一小部分患者中持续存在。外科医生应该了解最近认识到的暴露发展风险因素，并根据风险：效益评估仔细选择接受网片植入的患者。
合成网片经阴道植入用于妇科泌尿学适应证与公认的风险相关，包括暴露（约 10%）和收缩，通常可通过局部雌激素、门诊修剪或暴露或收缩段的手术切除成功处理。
